BASi opens new facility in Europe to better serve pharmaceutical and biotech companies
BASi has opened a new European laboratory and office in Warwickshire, UK. The relocation to a new, upgraded facility with significantly expanded laboratories provides clients with enhanced capabilities throughout Europe, according to the company.
Bioanalytical Systems, Inc. (BASi)
Like its North American counterparts, the new 10,000 square foot facility offers a comprehensive bioanalytical capability, as well as providing access to the BASi Group’s full range of preclinical and pharmaceutical analysis services for pharmaceutical and biotechnology companies. BASi Europe also supplies the complete line of BASi instruments and equipment, including the Culex Automated In Vivo Sampling System, as well as providing support for customers and distributors throughout Europe.
“BASi Europe offers over a thousand established and validated analytical methods and procedures,” said Mark Wareing, Managing Director of BASi Europe. “We currently have multiple industry standard LC-MS/MS stations, as well as LC-EC and other analytical technologies, and we have invested in two more high-sensitivity MS/MS instruments with state-of-the-art front-end analytical systems. We offer complete peace of mind with an enviable track record of delivering internationally compliant GLP/GCP regulated studies.”
Other news from the department business & finance
These products might interest you
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
